256 related articles for article (PubMed ID: 20616008)
1. Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model.
Kitamura T; Fujishita T; Loetscher P; Revesz L; Hashida H; Kizaka-Kondoh S; Aoki M; Taketo MM
Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13063-8. PubMed ID: 20616008
[TBL] [Abstract][Full Text] [Related]
2. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
[TBL] [Abstract][Full Text] [Related]
3. CCR1-mediated accumulation of myeloid cells in the liver microenvironment promoting mouse colon cancer metastasis.
Hirai H; Fujishita T; Kurimoto K; Miyachi H; Kitano S; Inamoto S; Itatani Y; Saitou M; Maekawa T; Taketo MM
Clin Exp Metastasis; 2014 Dec; 31(8):977-89. PubMed ID: 25326065
[TBL] [Abstract][Full Text] [Related]
4. SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion.
Kitamura T; Kometani K; Hashida H; Matsunaga A; Miyoshi H; Hosogi H; Aoki M; Oshima M; Hattori M; Takabayashi A; Minato N; Taketo MM
Nat Genet; 2007 Apr; 39(4):467-75. PubMed ID: 17369830
[TBL] [Abstract][Full Text] [Related]
5. Loss of SMAD4 Promotes Colorectal Cancer Progression by Accumulation of Myeloid-Derived Suppressor Cells through the CCL15-CCR1 Chemokine Axis.
Inamoto S; Itatani Y; Yamamoto T; Minamiguchi S; Hirai H; Iwamoto M; Hasegawa S; Taketo MM; Sakai Y; Kawada K
Clin Cancer Res; 2016 Jan; 22(2):492-501. PubMed ID: 26341919
[TBL] [Abstract][Full Text] [Related]
6. CCL15/CCR1 axis is involved in hepatocellular carcinoma cells migration and invasion.
Li Y; Wu J; Zhang P
Tumour Biol; 2016 Apr; 37(4):4501-7. PubMed ID: 26501423
[TBL] [Abstract][Full Text] [Related]
7. CCL9/CCR1 induces myeloid‑derived suppressor cell recruitment to the spleen in a murine H22 orthotopic hepatoma model.
Li B; Zhang S; Huang N; Chen H; Wang P; Yang J; Li Z
Oncol Rep; 2019 Jan; 41(1):608-618. PubMed ID: 30365155
[TBL] [Abstract][Full Text] [Related]
8. Disruption of CCR1-mediated myeloid cell accumulation suppresses colorectal cancer progression in mice.
Kiyasu Y; Kawada K; Hirai H; Ogawa R; Hanada K; Masui H; Nishikawa G; Yamamoto T; Mizuno R; Itatani Y; Kai M; Taketo MM; Sakai Y
Cancer Lett; 2020 Sep; 487():53-62. PubMed ID: 32473241
[TBL] [Abstract][Full Text] [Related]
9. Loss of SMAD4 Promotes Lung Metastasis of Colorectal Cancer by Accumulation of CCR1+ Tumor-Associated Neutrophils through CCL15-CCR1 Axis.
Yamamoto T; Kawada K; Itatani Y; Inamoto S; Okamura R; Iwamoto M; Miyamoto E; Chen-Yoshikawa TF; Hirai H; Hasegawa S; Date H; Taketo MM; Sakai Y
Clin Cancer Res; 2017 Feb; 23(3):833-844. PubMed ID: 27492974
[TBL] [Abstract][Full Text] [Related]
10. Control of both myeloid cell infiltration and angiogenesis by CCR1 promotes liver cancer metastasis development in mice.
Rodero MP; Auvynet C; Poupel L; Combadière B; Combadière C
Neoplasia; 2013 Jun; 15(6):641-8. PubMed ID: 23730212
[TBL] [Abstract][Full Text] [Related]
11. Keeping out the bad guys: gateway to cellular target therapy.
Kitamura T; Taketo MM
Cancer Res; 2007 Nov; 67(21):10099-102. PubMed ID: 17974948
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cell-derived CCL-9 and CCL-5 promote mammary tumor cell invasion and the activation of matrix metalloproteinases.
Swamydas M; Ricci K; Rego SL; Dréau D
Cell Adh Migr; 2013; 7(3):315-24. PubMed ID: 23722213
[TBL] [Abstract][Full Text] [Related]
13. Involvement of Macrophage Inflammatory Protein-1 Family Members in the Development of Diabetic Neuropathy and Their Contribution to Effectiveness of Morphine.
Rojewska E; Zychowska M; Piotrowska A; Kreiner G; Nalepa I; Mika J
Front Immunol; 2018; 9():494. PubMed ID: 29593735
[TBL] [Abstract][Full Text] [Related]
14. CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ.
Yan HH; Jiang J; Pang Y; Achyut BR; Lizardo M; Liang X; Hunter K; Khanna C; Hollander C; Yang L
Cancer Res; 2015 Dec; 75(24):5283-98. PubMed ID: 26483204
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional analysis of Ccr1l1, a Rodentia-restricted eosinophil-selective chemokine receptor homologue.
Kline JM; Heusinkveld LE; Taranto E; Martin CB; Tomasi AG; Hsu IJ; Cho K; Khillan JS; Murphy PM; Pontejo SM
J Biol Chem; 2021; 296():100373. PubMed ID: 33548230
[TBL] [Abstract][Full Text] [Related]
16. Influence of Chemokine N-Terminal Modification on Biased Agonism at the Chemokine Receptor CCR1.
Sanchez J; Lane JR; Canals M; Stone MJ
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096719
[TBL] [Abstract][Full Text] [Related]
17. Proteolytic activation of alternative CCR1 ligands in inflammation.
Berahovich RD; Miao Z; Wang Y; Premack B; Howard MC; Schall TJ
J Immunol; 2005 Jun; 174(11):7341-51. PubMed ID: 15905581
[TBL] [Abstract][Full Text] [Related]
18. CCL15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular Carcinoma.
Liu LZ; Zhang Z; Zheng BH; Shi Y; Duan M; Ma LJ; Wang ZC; Dong LQ; Dong PP; Shi JY; Zhang S; Ding ZB; Ke AW; Cao Y; Zhang XM; Xi R; Zhou J; Fan J; Wang XY; Gao Q
Hepatology; 2019 Jan; 69(1):143-159. PubMed ID: 30070719
[TBL] [Abstract][Full Text] [Related]
19. CCR1/CCL5 interaction promotes invasion of taxane-resistant PC3 prostate cancer cells by increasing secretion of MMPs 2/9 and by activating ERK and Rac signaling.
Kato T; Fujita Y; Nakane K; Mizutani K; Terazawa R; Ehara H; Kanimoto Y; Kojima T; Nozawa Y; Deguchi T; Ito M
Cytokine; 2013 Oct; 64(1):251-7. PubMed ID: 23876400
[TBL] [Abstract][Full Text] [Related]
20. CpG-ODNs induces up-regulated expression of chemokine CCL9 in mouse macrophages and microglia.
Ravindran C; Cheng YC; Liang SM
Cell Immunol; 2010; 260(2):113-8. PubMed ID: 19883904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]